1 April 2024 false No description of principal activity Taxfiler 2024.6 11834573business:PrivateLimitedCompanyLtd2024-04-012025-03-31 118345732024-03-31 118345732024-04-012025-03-31 11834573business:AuditExemptWithAccountantsReport2024-04-012025-03-31 11834573business:FilletedAccounts2024-04-012025-03-31 118345732025-03-31 11834573business:Director12024-04-012025-03-31 11834573business:Director32024-04-012025-03-31 11834573business:Director52024-04-012025-03-31 11834573business:CompanySecretary12024-04-012025-03-31 11834573business:RegisteredOffice2024-04-012025-03-31 118345732024-03-31 11834573core:WithinOneYear2025-03-31 11834573core:WithinOneYear2024-03-31 11834573core:AfterOneYear2025-03-31 11834573core:AfterOneYear2024-03-31 11834573core:ShareCapitalcore:PreviouslyStatedAmount2025-03-31 11834573core:ShareCapitalcore:PreviouslyStatedAmount2024-03-31 11834573core:SharePremiumcore:PreviouslyStatedAmount2025-03-31 11834573core:SharePremiumcore:PreviouslyStatedAmount2024-03-31 11834573core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-03-31 11834573core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-03-31 11834573core:PreviouslyStatedAmount2025-03-31 11834573core:PreviouslyStatedAmount2024-03-31 11834573business:SmallEntities2024-04-012025-03-31 11834573countries:EnglandWales2024-04-012025-03-31 11834573core:ComputerEquipment2024-04-012025-03-31 11834573core:ComputerEquipment2024-03-31 11834573core:ComputerEquipment2025-03-31 11834573core:WithinOneYear2024-04-012025-03-31 11834573core:AfterOneYear2024-04-012025-03-31 118345732023-04-012024-03-31 iso4217:GBP xbrli:pure
Company Registration No. 11834573 (England and Wales)
Presymptom Health Limited Unaudited accounts for the year ended 31 March 2025
Presymptom Health Limited Unaudited accounts Contents
Page
- 2 -
Presymptom Health Limited Company Information for the year ended 31 March 2025
Directors
Tito Adolfo Bacarese-Hamilton Mark Gostock Nadia Whittley
Secretary
MBM Secretarial Services Ltd
Company Number
11834573 (England and Wales)
Registered Office
1 Aire Street Leeds LS1 4PR United Kingdom
Accountants
Forest Edge Accountancy 2 Appletree Close Redlynch Salisbury Wiltshire SP5 2JG
- 3 -
Presymptom Health Limited Statement of financial position as at 31 March 2025
2025 
2024 
Notes
£ 
£ 
Fixed assets
Tangible assets
347 
694 
Current assets
Debtors
147,535 
2,925 
Cash at bank and in hand
69,476 
1,028,953 
217,011 
1,031,878 
Creditors: amounts falling due within one year
(43,116)
(69,096)
Net current assets
173,895 
962,782 
Total assets less current liabilities
174,242 
963,476 
Creditors: amounts falling due after more than one year
(1,128,986)
(1,026,986)
Net liabilities
(954,744)
(63,510)
Capital and reserves
Called up share capital
136 
136 
Share premium
622,558 
622,558 
Profit and loss account
(1,577,438)
(686,204)
Shareholders' funds
(954,744)
(63,510)
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 11 September 2025 and were signed on its behalf by
Nadia Whittley Director Company Registration No. 11834573
- 4 -
Presymptom Health Limited Notes to the Accounts for the year ended 31 March 2025
1
Statutory information
Presymptom Health Limited is a private company, limited by shares, registered in England and Wales, registration number 11834573. The registered office is 1 Aire Street, Leeds, LS1 4PR, United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Consultancy Fees
During the year consultancy fees of £183,127 were paid. The largest payments were paid to Granted Consultancy Limited for £48,600, Davison Dx Consulting for £35,970 and Charité Universitätsmedizin Berlin for £31,320.
Other Legal and Professional
These fees are expenses relating to Clinical Trials (£222,490).
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
3 years straight line
4
Tangible fixed assets
Computer equipment 
£ 
Cost or valuation
At cost 
At 1 April 2024
1,041 
At 31 March 2025
1,041 
Depreciation
At 1 April 2024
347 
Charge for the year
347 
At 31 March 2025
694 
Net book value
At 31 March 2025
347 
At 31 March 2024
694 
- 5 -
Presymptom Health Limited Notes to the Accounts for the year ended 31 March 2025
5
Debtors
2025 
2024 
£ 
£ 
Amounts falling due within one year
Trade debtors
142,303 
- 
Accrued income and prepayments
5,232 
864 
Other debtors
- 
2,061 
147,535 
2,925 
6
Creditors: amounts falling due within one year
2025 
2024 
£ 
£ 
VAT
(10,013)
(37,343)
Trade creditors
38,700 
90,654 
Taxes and social security
10,244 
10,891 
Other creditors
3,435 
4,144 
Accruals
750 
750 
43,116 
69,096 
UK Innovation & Science Seed Fund LP has provided a loan to the company of £1,708. This remains unpaid as at the year end.
7
Creditors: amounts falling due after more than one year
2025 
2024 
£ 
£ 
Other creditors
1,128,986 
1,026,986 
This CLN with initial investments of £500,000 provided by Ploughshare Innovations Limited, £20,000 from Medtechtomarket Consulting Limited and £500,000 from Prism (General Partner) Ltd. This CLN during the year, has accrued interest as agreed.
8
Average number of employees
During the year the average number of employees was 3 (2024: 3).
- 6 -